Hip osteoarthritis damages the cartilage lining the hip joint, leading to pain in the groin or buttock, stiffness, and difficulty walking or climbing stairs. Treatment focuses on reducing pain, maintaining mobility, and preserving hip function for as long as possible.
Conservative management is the foundation: activity modification (avoiding high-impact exercise), physiotherapy to strengthen hip stabiliser muscles, and weight management to reduce joint load. Analgesics such as paracetamol or NSAIDs (ibuprofen, diclofenac) provide pain control; some patients use topical NSAIDs to minimise systemic side effects. Walking aids and hip supports reduce strain. Intra-articular corticosteroid or hyaluronic-acid injections are effective for moderate OA, though hip anatomy makes injections technically more challenging than in the knee. When conservative measures fail and function is severely compromised, total hip replacement is highly successful and durable, typically lasting 15–20 years.
Manual osteopathic therapy and massage targeting hip flexibility may complement physio. Herbal anti-inflammatories (turmeric, boswellia) are used but evidence remains limited. Aquatic exercise and tai chi offer low-impact mobility training. Some centres offer PRP injections to the hip joint, though data on efficacy in hip OA is less robust than in the knee. Mindfulness and pain-coping strategies help manage chronic hip discomfort.
Stem-cell therapies for hip OA are in early investigation, with research exploring whether bone-marrow or adipose-derived mesenchymal stem cells can reduce inflammation and promote cartilage repair in the hip joint. Hip anatomy and biomechanics differ from the knee, and clinical evidence is limited. Regenerative approaches remain non-standard and candidacy should be evaluated by a hip specialist. Learn more at regenerative options for hip OA and candidate selection.
| Option | Type | Evidence | Indicative cost | Invasiveness | Recovery |
|---|---|---|---|---|---|
| Physiotherapy & mobility exercises | Standard | Strong | €50–100 per session | Low | Ongoing; 6–12 weeks to progress |
| NSAIDs (oral or topical) | Standard | Strong | €5–80/month | Low | Immediate; GI risk with long-term oral |
| Corticosteroid injections (hip) | Standard | Moderate | €250–500 | Medium | Few days; effects 4–8 weeks |
| Hyaluronic-acid injections (hip) | Standard | Limited | €500–1,000 | Medium | Few days; effects variable in hip |
| Total hip replacement | Standard | Strong | €18,000–40,000 | High | 8–12 weeks; durable 15–20 years |
| Osteopathic manual therapy | Alternative | Limited | €80–150 per session | Low | None; ongoing sessions |
| PRP therapy (hip) | Alternative | Limited | €600–2,000 | Medium | Few days; evidence limited for hip |
| Stem-cell therapy | Regenerative | Investigational | €5,000–18,000 | Medium | 2–4 weeks; early-stage research |
Hip anatomy is complex, the joint is deeply positioned, and injections require image guidance. The hip bears significant load during walking, making it harder to offload than the knee. However, hip replacement is highly effective when needed.
Consider surgery when conservative treatment no longer controls pain or restores function, affecting daily activities and quality of life. Modern hip replacements last 15–20 years. Age alone is not a barrier; timing depends on your functional needs and surgeon assessment.
Injections may provide relief for several months and, combined with physiotherapy, can delay progression. However, they do not reverse cartilage damage. Whether they prevent eventual replacement varies by individual; discuss prognosis with your orthopaedic surgeon.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Educational overview of treatment options; not medical advice. Standard treatments reflect mainstream guidance; regenerative/stem-cell uses are largely investigational. Reviewed by the StemCellAtlas editorial team.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite